WARWICK – Kent Hospital was chosen as one of 80 hospitals to participate in a worldwide clinical trial to evaluate the effectiveness of a new clot-dissolving drug, Desmoteplase. More
This item is available in full to subscribers. If you are a current subscriber, log in to continue.